Maintaining the authenticity of medicinal materials ensures effective competitiveness for enterprises
Release time:
2020-09-22
With market expansion, dwindling wild resources, and an aging workforce, the demand cannot be met. Therefore, the cultivation of Tripterygium wilfordii, characterized by standardized management and production, is the primary industry and foundation for the development of the entire Tripterygium wilfordii industry.
With the continuous expansion of the market, the increasing scarcity of wild resources, and the aging workforce, the market demand cannot be met. Therefore, the cultivation of Stephania tetrandra, characterized by standardized management and standardized production, is the primary industry in the entire Stephania tetrandra industry and the foundation for the development of the entire industry. It provides the scarce raw materials for the Stephania tetrandra industry, maintains the authenticity of the medicinal materials, and maintains effective competitiveness for enterprises. The company has always prioritized the construction of Stephania tetrandra planting bases. Through repeated screening and tracking and testing of various high-quality producing areas of Stephania tetrandra, the "Zhejiang Teng No. 1" Stephania tetrandra variety planting project based on the company's Hengbanqiao base has been steadily progressing. Currently, corresponding planting bases have been established in Xinchang, Hunan, and Hubei.
As a leading enterprise in Stephania tetrandra Chinese medicine preparations, in 2002, under the technical guidance of the Provincial Institute of Chinese Materia Medica, the company conducted research on the standardized cultivation of wild plants to domesticated plants, formulated the provincial local standard "Technical Specifications for Stephania tetrandra Planting," and formed an "enterprise + base + farmer" operation model to provide technical guidance and assistance to a large number of planting farmers. By 2025, the goal of the core demonstration base is to complete 3,000 mu. Based on the company's standardized demonstration base for Stephania tetrandra, the planting area will be expanded. In March 2018, planting agreements of 300 mu and 1,000 mu were signed with customers in Hubei and Hunan, respectively. Approximately 800 mu of planting area has been completed, and it is planned to complete 1,500 mu of planting in 2023.
Stephania tetrandra is a local medicinal material in our Xinchang. The company focuses the work of the standardized demonstration planting base of Stephania tetrandra on local promotion in Xinchang. It has also received great attention from the Xinchang agricultural department and various townships. In 2020, under the leadership of Mr. Jin Chunhui, chairman of the company, preliminary cooperation intentions were discussed with the leaders of Huishan Town. Currently, the Stephania tetrandra seedling work of Shuangcai Tea Plantation has been completed, and 200 mu of Stephania tetrandra planting will be completed in the second half of the year.
In order to further promote the planting area of Stephania tetrandra and improve the medicinal properties of the medicinal materials, the planting base will use Zhejiang De'en De Pharmaceutical Co., Ltd. as a platform and technical support. Based on "Zhejiang Teng No. 1," it will continue to cultivate new high-content varieties of Stephania tetrandra, continuously expand the planting area of Stephania tetrandra, drive the local economy, develop local farmers' planting, establish a local 1,000-mu demonstration base for Stephania tetrandra, and make the planting of medicinal materials standardized, characteristic, and industrialized, creating more economic and social benefits for Xinchang.
Recommended information
Your email address
If you are interested in our products, please leave your email.
Our products
Contact information
Address: No. 2, East National Road, Ru'ao Town, Xinchang County, Shaoxing City, Zhejiang Province
Email:dndlxb@126.com
Tel:
0575-8606-0282(Administration)
0575-8678-0003(Human Resources)
0575-8678-0050(Sales)
© Zhejiang Deende Pharmaceutical Co., Ltd.All rights reserved. Powered by:www.300.cn